Plant-derived extracellular vesicles (PDEVs): Why parsley is particularly interesting
The paper you linked, Plant-derived extracellular vesicles as natural nucleic acid carriers in gut-liver communication, published October 16, 2026, explores a fascinating possibility: plants may influence animal physiology not just through nutrients and phytochemicals, but by delivering membrane-packaged molecular cargo that changes how recipient cells behave.
And parsley turns out to have some particularly interesting experimental evidence, although it isn’t discussed in this particular review.
The biggest distinction is between two proposed mechanisms:
- Biochemical signaling: Plant vesicles deliver lipids, metabolites, proteins, or other components that affect inflammation, cellular stress, or metabolism.
- Cross-kingdom genetic regulation: Plant vesicles transport small RNAs into animal cells, where those RNAs interfere with mammalian gene expression.
The first is experimentally plausible and supported by several preclinical studies. The second is considerably more controversial.
1. What exactly are PDEVs?
PDEVs are nanoscale, lipid-membrane-enclosed particles produced by plants or recovered from plant tissues.
Property Typical characteristics Diameter Approximately 30–200 nm in many preparations Membrane Lipid bilayer Cargo Small RNAs, proteins, lipids, metabolites, sometimes DNA Potential destinations Intestinal epithelial cells, immune cells, microbiota, potentially other tissues Natural functions Plant defense, communication, transport of biological material Pharmaceutical interest Oral delivery of drugs and nucleic acids Unlike a purified chemical such as apigenin, a PDEV is a complex particle whose membrane, internal cargo, and interactions with target cells can all contribute to biological activity.
One crucial complication: researchers often obtain these particles by crushing or juicing plants. This creates mixtures of genuine extracellular vesicles, intracellular membrane fragments, and other nanoparticles. Not everything marketed as a plant exosome is necessarily a bona fide extracellular vesicle.
2. Parsley PDEVs: The University of Tokyo experiments
Petroselinum crispum
Parsley belongs to the Apiaceae family, alongside carrots, celery, coriander, dill, and fennel.
Its vesicles are being studied for anti-inflammatory, muscle-protective, and potential anti-senescence effects.
I found two particularly relevant patent disclosures from the University of Tokyo:
- Anti-inflammatory and aging-suppressing compositions
- New methods for isolating plant EVs
These are not peer-reviewed clinical publications, but they contain original experiments, including mouse studies and a small, incompletely reported human observation. That’s considerably more evidence than simply extrapolating from other vegetables.
What did the parsley experiments show?
Experiment Reported findings Evidence level Mouse macrophages Reduced LPS-induced inflammatory gene expression, including IL-6 and IL-1β Cell culture RNA sequencing 1,042 genes showed reduced expression in one parsley-EV treatment comparison Cell culture Induced colitis Reported protection against inflammatory intestinal injury Mice Diet-induced obesity Improved grip strength and increased soleus muscle weight relative to obese controls Mice Muscle endurance Favorable trend, but not statistically significant for parsley Mice Skin appearance Improvements reported after five weeks of oral intake Uncontrolled or insufficiently described human observation The most interesting result: 1,042 downregulated genes
The 2026 patent describes exposing mouse macrophages to parsley-derived vesicle preparations, followed by lipopolysaccharide (LPS), which triggers a strong innate immune inflammatory response.
The depth-filtered preparations suppressed several inflammatory transcripts:
Conceptual mechanism. The patent measures downstream inflammatory gene expression; it does not establish exactly where the vesicles intervene in the signaling pathway.
The reported affected genes include:
- IL6: A major inflammatory and immune-signaling cytokine.
- IL1B: An inflammatory cytokine associated with inflammasome-related responses.
- CXCL2 and CXCL3: Chemokines involved in recruiting immune cells, particularly neutrophils.
- TGFB1: A context-dependent regulator of immune suppression, tissue remodeling, and fibrosis.
The particularly intriguing finding is that the isolation method changed the biological activity. Depth filtration and a settling-based approach produced preparations with stronger effects than centrifugation-based isolation.
That raises a mechanistic question: are the more active preparations selecting a particular vesicle subpopulation, preserving delicate membrane structures, or retaining additional bioactive molecules?
The current data don’t distinguish those possibilities.
Parsley EVs and intestinal barrier protection
The 2025 patent reports a particularly interesting experiment using DSS-induced colitis in mice.
They administered 10¹¹ parsley-derived particles per mouse daily, beginning one week before DSS exposure and continuing during the inflammatory challenge.
Control mice
100%
Had visible anal bleeding by day 7
Parsley-EV mice
50%
Had visible anal bleeding by day 7
The investigators also reported:
- Reduced colonic IL-6 expression.
- Preservation of Alcian-blue-positive intestinal mucus.
- Better maintenance of epithelial architecture.
- Retention of β-catenin and ZO-1-associated epithelial structures.
These findings suggest protection of the mucus and epithelial barriers, not merely lower inflammatory markers. But the patent does not establish whether the effect comes from vesicle-contained RNA, vesicle lipids, or co-isolated parsley metabolites. Nor does it establish efficacy in human inflammatory bowel disease.
Muscle preservation: Unexpectedly interesting for aging research
In another experiment, mice received parsley or Brussels sprout EVs in drinking water for 13 weeks while eating a high-fat diet.
The parsley-treated group showed higher grip-strength measurements and significantly greater soleus muscle weight compared with untreated obese mice. Four-limb hanging performance showed a favorable trend, but it did not reach statistical significance for parsley.
This raises possible connections with inflammatory muscle wasting, muscle regeneration, and metabolic stress, but the study did not demonstrate increased muscle protein synthesis or reversal of age-related sarcopenia. These were obesity-challenged mice, not naturally aged mice.
What about actual humans?
The same patent describes oral consumption of 8 × 10¹² freeze-dried parsley-derived particles daily for five weeks, followed by VISIA facial-skin imaging.
It reports improvements in pigmentation, texture, redness, pores, and other appearance measures.
However, the accessible disclosure does not adequately establish sample size, randomization, blinding, placebo control, or independent statistical validation. So this is an exploratory observation, not clinical proof that parsley EVs rejuvenate skin.
3. The major 2026 development: Parsley PDEVs reached a randomized human trial
TIME TRAVELER
The University of Tokyo-linked startup behind the parsley-PDEV supplement exofull FUJI.
In August 2026, TIME TRAVELER–Plant-EVs became one of ten XPRIZE Healthspan Milestone 2 awardees, receiving $1 million. XPRIZE lists 20 finalist teams overall.
More importantly, I located the actual Japanese clinical-trial registration:
UMIN000059942: Exploratory study of physical, immune, and cognitive function.
Registered human study December 2025–2026
40
Planned participants
8
Weeks of treatment
55–69
Age range
Randomized, double-blind, placebo-controlled, parallel-group design. The company reports that 39 participants completed the trial.
Registered outcome measures
Physical function: VO₂max, grip strength, leg strength, muscle mass, Timed Up and Go.
Immunity/inflammation: NK-cell activity, IL-6, GDF15, LPS.
Cognition and sleep: Cognitrax, Athens Insomnia Scale.
This is a meaningful step beyond the patent observations. However, the trial registry still lists the results as unpublished, with no publicly reported treatment-versus-placebo numerical outcomes. XPRIZE selection indicates that the judges evaluated submitted data, not that any specific magnitude of rejuvenation has been independently established.
The most interesting future evidence will be whether parsley PDEVs improve muscle, immune, and cognitive function simultaneously, and whether those improvements replicate in larger cohorts.
4. How could plant vesicles actually affect humans?
The gut is the most plausible first destination.
Proposed gut–liver signaling network
Conceptual pathways, not a demonstration that intact parsley vesicles reach the human liver.
The review describes three routes of biological influence.
Direct host-cell effects. Vesicles interact with intestinal epithelial cells and macrophages, potentially affecting barrier integrity, inflammatory signaling, and tissue repair. Several animal studies report suppression of NLRP3-associated inflammation.
Microbiome-mediated effects. Plant particles or their cargo can interact with bacteria, potentially modifying microbial gene expression and metabolism.
Systemic effects. Vesicles or their constituents might cross the intestinal barrier, travel through portal blood or lymph, and influence liver or other tissues. This last route is much less conclusively established, especially in humans.
A particularly interesting precedent: Ginger EVs program bacterial metabolism
A 2018 Cell Host & Microbe study described ginger-derived vesicles being taken up by Lactobacillus rhamnosus.
The researchers proposed the following chain:
Ginger EV-associated mdo-miR7267-3p
Targeting of bacterial ycnE monooxygenase
Increased indole-3-carboxaldehyde production
Altered intestinal immune signaling
This is important because a plant RNA might modify mammalian physiology without ever needing to enter a mammalian nucleus or participate in mammalian RNA interference. It could instead act on an intermediary organism.
That makes the microbiome a potentially more accessible target for dietary plant RNAs than distant human tissues, though these mechanisms still need independent replication and quantitative validation.
5. Why the genetic-regulation hypothesis is still controversial
The review revisits the famous rice miR168a finding from 2012, which proposed that plant microRNA could enter mammals and inhibit LDLRAP1, a gene involved in LDL receptor trafficking.
Follow-up investigations often failed to reproduce meaningful dietary uptake.
The critical obstacles include extremely low RNA copy numbers, degradation during digestion, inefficient delivery into cells, difficulty loading plant RNA into mammalian Argonaute complexes, and sequencing contamination.
It helps to distinguish three statements:
Claim Current interpretation Plant vesicle preparations affect animal biology Supported in multiple preclinical models Vesicle-contained RNA mediates some effects Supported in selected studies, but often incompletely proven Dietary plant RNA routinely controls genes in distant human organs Unproven and controversial For parsley specifically, no particular miRNA has yet been established as the causal ingredient responsible for the reported anti-inflammatory or muscle effects.
An alternative is that the activity arises from membrane lipids, parsley phytochemicals, or combinations of components. Parsley contains compounds such as apigenin and related flavonoids, but whether these are enriched in the relevant vesicle fractions at functionally important concentrations has not been demonstrated.
6. What makes parsley vesicles unusual technologically?
The University of Tokyo patents report several useful preparation characteristics.
Reported mean particle size
148 nm
Ultrafiltered parsley preparation
Reported size range
50–300 nm
Nanoparticle tracking analysis
Interesting processing result
The 2025 patent reports retention of IL-6-suppressing activity following heating at 65°C for 10 minutes or 85°C for 30 minutes.
That finding is intriguing because EV research often emphasizes preserving fragile lipid membranes. But retention of a functional assay signal after heating does not prove the vesicles remained structurally intact or preserved their original RNA cargo.
The commercial parsley formulation uses a proprietary low-temperature, freeze-drying process, so the patent’s heat-stability experiment and the marketed manufacturing method address different questions.
7. Is eating parsley equivalent to taking purified parsley PDEVs?
Not demonstrably.
Fresh parsley likely contains nanoscale membrane structures, but ordinary consumption and concentrated particle preparations differ in several ways:
Ordinary parsley Concentrated parsley-EV preparations Whole plant matrix Particles enriched by filtration or centrifugation Substantial fiber and phytochemical exposure Much higher targeted particle exposure may be possible Digestion releases a heterogeneous mixture Manufacturing changes the particle mixture Established food history Limited product-specific long-term human safety data The marketed exofull FUJI currently lists a 30-capsule package at ¥11,000, with one 300 mg capsule recommended daily.
Crucially, the accessible product page does not specify an exact particle count per capsule. Therefore, I cannot establish whether its standard daily dose resembles the 8 × 10¹² particles/day used in the patent’s five-week skin observation. The randomized trial’s full dose-response results are also unavailable.
I would not assume that taking more capsules recreates a research exposure. Concentration, purity, formulation, and safety matter as much as nominal particle counts.
8. The experiments I would most want to see next
The parsley program is now at a particularly interesting fork. It has functional observations but has not resolved the identity of the active molecules.
A decisive study would fractionate the preparation and independently test intact vesicles, ruptured vesicles, isolated lipid fractions, RNA-depleted preparations, and soluble non-vesicular fractions.
For the RNA hypothesis, the strongest test would be to identify candidate parsley RNAs, quantify their abundance per particle, demonstrate delivery into recipient cells, and show loss of biological activity when a candidate RNA is specifically depleted, followed by rescue.
For the alternative lipid/metabolite hypothesis, lipidomics and untargeted metabolomics, followed by activity-guided fractionation, might reveal whether a much smaller set of molecules can reproduce the effect.
For systemic delivery, dual labeling of membrane and cargo, alongside portal-blood pharmacokinetics, would help distinguish intact particle transport from absorption of degradation products. This is a key distinction emphasized by the review and MISEV2023 guidelines.
My assessment
Parsley PDEVs deserve scientific attention, particularly because they have moved beyond generic plant-vesicle speculation into original cell and mouse experiments, a registered randomized human trial, and an internationally recognized longevity research program.
The strongest parsley-specific preclinical evidence concerns modulation of inflammatory responses and preservation of intestinal barrier architecture. The muscle observations are interesting but less decisive. The human healthspan results are not yet publicly interpretable.
The most compelling possibility is not necessarily that parsley delivers its own genetic instructions directly into human cells. It may be that different plant-derived nanoparticles are complex, evolutionarily shaped combinations of lipids and metabolites that modulate local immune and microbial networks. If their useful properties can be isolated and engineered, they could become a genuinely different class of oral biologic.
For parsley, the decisive outstanding question is simple: What specific molecular feature makes the active preparation work, and does that same feature produce a reproducible benefit in humans?
The 2026 randomized trial, followed by the more rigorous XPRIZE trials planned through 2029, should help separate those possibilities.
I can also track the publication of UMIN000059942’s full outcomes, particularly VO₂max, grip strength, GDF15, NK-cell activity, and Cognitrax, and notify you when numerical results become public.
trend, therefore, is to characterise EVs in terms of mesoscale signatures like their mechanical properties, that can be measured, for example, by Atomic Force Microscopy (AFM),21,39,40 3D-AFM,26 and non-contact microfluidics.41 In addition, the elasticity of engineered drug delivery nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting.42
Mechanical properties are important not only for purification but also for diagnostics. Diagnostic assays, however, typically employ only biochemical markers as membrane proteins. Whitehead et al7 showed that the use of mechanical properties could significantly expand the power of diagnostic assays. In their study, Whitehead et al. compared EVs released by healthy and cancer urothelial cells that were undistinguishable on the basis of all known biochemical markers and could only be discriminated considering their mechanical properties. In particular, they observed that EVs released by cells derived from bladder carcinoma tend to be softer than those produced by healthy urothelial cells. These results are in agreement with the findings of LeClaire8 showing a progressive softening of the EV membrane as breast-derived cells progress towards malignancy and invasivity. In this work, we focused on the EVs released by the prostate cancer cell line PC-3, together with their healthy counterpart, the prostasomes. In agreement with Whitehead7 and LeClaire,8 we found different values of the tilt and splay moduli, but the cancerous PC-3 vesicles turned out to be stiffer than the healthy prostasomes. Our detailed analysis of the contributions of each lipid type to the overall elastic moduli of the membrane underscores a complex interplay among lipid types, with the reduction in cholesterol content providing the dominant contribution to the stiffening of PC-3 cancerous EV membranes (Fig. 4), similar to the role that it has in sphingomyelin membranes.27 These results suggest that, in each type of cancer, the EV membrane can become more 21,26 or less 7,8 rigid than that of healthy vesicles, so that the diagnostic interpretation of mechanical properties will have to be made case-by-case. This nuanced scenario underscores the need for systematic experimental measurements of the mechanical properties of EVs at different cancer stages to confirm the present predictions and, more generally, to identify diagnostically relevant trends. Additionally, biofluids usually contain only a minor fraction of EVs, which poses practical challenges to the use of the proposed mechanophenotyping strategy. Nonetheless, this approach has been demonstrated in EVs isolated from blood and bone marrow samples,21 can be implemented using high-throughput techniques,40,43 and could serve as the basis for multimodal EV screening.44
Many of the results of this work originate in the asymmetric composition of EV membranes and therefore go much beyond the scope of prostate cancer diagnostics. Membrane asymmetry, that has been known to the biophysical community since the early 1970s,45 can be considered as an almost universal property of biological membranes, with conservation in all kingdoms of nature. However, the study of asymmetry was severely limited by the difficulty in producing model membranes with a simplified composition. Recently, this problem has been solved with the advent of the phase transfer technique46 that allows the assembly of lipid bilayers with tailored composition. Using this approach, the bending modulus of an asymmetric DOPC/POPC membrane was measured showing that the asymmetric membrane is much more rigid than both corresponding symmetric bilayers.46 These results, however, have been questioned on theoretical grounds by Hossein and Deserno28 who suggested that the creation of compositionally asymmetric membranes may induce an accidental differential stress so that the membrane looks stiffer than it actually is. According to this interpretation, in the mentioned experiment, it is number asymmetry rather than composition asymmetry that affects the rigidity of a membrane.